春寒
2017-04-05
$Eleven Biotherapeutics Inc.(EBIO)$ 这股有毛病!!
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP,发表看法
APP内打开
发表看法
3
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":52747,"tweetId":"52747","gmtCreate":1491404351013,"gmtModify":1704876117598,"author":{"id":223455071516885,"idStr":"223455071516885","authorId":223455071516885,"authorIdStr":"223455071516885","name":"春寒","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":4,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>$Eleven Biotherapeutics Inc.(EBIO)$ 这股有毛病!!</p></body></html>","htmlText":"<html><head></head><body><p>$Eleven Biotherapeutics Inc.(EBIO)$ 这股有毛病!!</p></body></html>","text":"$Eleven Biotherapeutics Inc.(EBIO)$ 这股有毛病!!","highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/52747","repostId":0,"isVote":1,"tweetType":1,"viewCount":1633,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["EBIO"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":45,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/52747"}
精彩评论